JP2004523553A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004523553A5 JP2004523553A5 JP2002567289A JP2002567289A JP2004523553A5 JP 2004523553 A5 JP2004523553 A5 JP 2004523553A5 JP 2002567289 A JP2002567289 A JP 2002567289A JP 2002567289 A JP2002567289 A JP 2002567289A JP 2004523553 A5 JP2004523553 A5 JP 2004523553A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- formula
- composition
- group
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002193 Pain Diseases 0.000 claims 29
- 239000000203 mixture Substances 0.000 claims 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 12
- 229910052801 chlorine Inorganic materials 0.000 claims 6
- 239000000460 chlorine Substances 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- 208000000094 Chronic Pain Diseases 0.000 claims 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 3
- 208000005298 acute pain Diseases 0.000 claims 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 3
- 229910052794 bromium Inorganic materials 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 239000011737 fluorine Substances 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 208000014674 injury Diseases 0.000 claims 3
- 229910052740 iodine Inorganic materials 0.000 claims 3
- 239000011630 iodine Substances 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 201000008482 osteoarthritis Diseases 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 238000001356 surgical procedure Methods 0.000 claims 3
- 208000008035 Back Pain Diseases 0.000 claims 2
- 206010006002 Bone pain Diseases 0.000 claims 2
- 208000034656 Contusions Diseases 0.000 claims 2
- 230000009692 acute damage Effects 0.000 claims 2
- 230000000747 cardiac effect Effects 0.000 claims 2
- 230000009519 contusion Effects 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 230000008733 trauma Effects 0.000 claims 2
- 208000030507 AIDS Diseases 0.000 claims 1
- 206010008479 Chest Pain Diseases 0.000 claims 1
- 208000005171 Dysmenorrhea Diseases 0.000 claims 1
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 208000037767 Gallbladder pain Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 208000000913 Kidney Calculi Diseases 0.000 claims 1
- 208000007914 Labor Pain Diseases 0.000 claims 1
- 208000008930 Low Back Pain Diseases 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010028836 Neck pain Diseases 0.000 claims 1
- 206010029148 Nephrolithiasis Diseases 0.000 claims 1
- 208000001294 Nociceptive Pain Diseases 0.000 claims 1
- 206010062501 Non-cardiac chest pain Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 208000000450 Pelvic Pain Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010037779 Radiculopathy Diseases 0.000 claims 1
- 208000025747 Rheumatic disease Diseases 0.000 claims 1
- 208000026137 Soft tissue injury Diseases 0.000 claims 1
- 208000020339 Spinal injury Diseases 0.000 claims 1
- 208000010040 Sprains and Strains Diseases 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 208000000718 duodenal ulcer Diseases 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- 208000001130 gallstones Diseases 0.000 claims 1
- 201000005917 gastric ulcer Diseases 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 208000037821 progressive disease Diseases 0.000 claims 1
- 230000000552 rheumatic effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 230000002123 temporal effect Effects 0.000 claims 1
- 210000002435 tendon Anatomy 0.000 claims 1
- 206010048627 thoracic outlet syndrome Diseases 0.000 claims 1
- 208000037816 tissue injury Diseases 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27188801P | 2001-02-27 | 2001-02-27 | |
| PCT/US2002/005421 WO2002067922A1 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in the treatment of pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004523553A JP2004523553A (ja) | 2004-08-05 |
| JP2004523553A5 true JP2004523553A5 (cg-RX-API-DMAC10.html) | 2005-12-22 |
| JP4276838B2 JP4276838B2 (ja) | 2009-06-10 |
Family
ID=23037511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567289A Expired - Fee Related JP4276838B2 (ja) | 2001-02-27 | 2002-02-21 | 疼痛(pain)の治療における使用のためのカルバメート化合物 |
Country Status (28)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003007934A1 (en) * | 2001-07-16 | 2003-01-30 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| EP1998781A2 (en) * | 2006-03-24 | 2008-12-10 | Wyeth a Corporation of the State of Delaware | Treatment of pain |
| US20100160351A1 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| WO2010071865A1 (en) | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| WO2011032175A1 (en) | 2009-09-14 | 2011-03-17 | Nuon Therapeutics, Inc. | Combination formulations of tranilast and allopurinol and methods related thereto |
| EP2496227B1 (en) | 2009-11-06 | 2019-05-22 | SK Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
| ES2447295T3 (es) | 2009-11-06 | 2014-03-11 | Sk Biopharmaceuticals Co., Ltd. | Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CN102266317A (zh) * | 2011-06-24 | 2011-12-07 | 中国人民解放军第三军医大学 | 丙戊酸及其衍生物的应用 |
| RU2632659C2 (ru) * | 2011-12-27 | 2017-10-09 | Байо-Фарм Солюшнс Ко., Лтд. | Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии |
| JP6062077B2 (ja) | 2013-03-12 | 2017-01-18 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes} |
| KR102421013B1 (ko) * | 2016-05-19 | 2022-07-14 | 에스케이바이오팜 주식회사 | 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3278380A (en) * | 1962-02-06 | 1966-10-11 | Armour Pharma | Methods of calming employing diphenyl hydroxy carbamate compounds |
| US3265728A (en) | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| RU2020972C1 (ru) * | 1991-02-07 | 1994-10-15 | Мегдятов Рашид Салехович | Способ лечения невралгии тройничного нерва |
| US5698588A (en) | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| ATE226071T1 (de) * | 1996-10-08 | 2002-11-15 | Ortho Mcneil Pharm Inc | Antikonvulsive derivate zur behandlung von neuropathischem schmerz |
| GB2340074A (en) * | 1998-08-01 | 2000-02-16 | Max Imaging Systems Limited | Printing process |
| PL365701A1 (en) | 2000-07-21 | 2005-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
-
2002
- 2002-02-21 MX MXPA03007721A patent/MXPA03007721A/es active IP Right Grant
- 2002-02-21 RU RU2003128984/14A patent/RU2283106C2/ru not_active IP Right Cessation
- 2002-02-21 US US10/081,943 patent/US6815464B2/en not_active Expired - Fee Related
- 2002-02-21 IL IL15759302A patent/IL157593A0/xx unknown
- 2002-02-21 CN CNA028089227A patent/CN1849116A/zh active Pending
- 2002-02-21 CZ CZ20032298A patent/CZ20032298A3/cs unknown
- 2002-02-21 WO PCT/US2002/005421 patent/WO2002067922A1/en not_active Ceased
- 2002-02-21 RS YUP-676/03A patent/RS67603A/sr unknown
- 2002-02-21 DE DE60238765T patent/DE60238765D1/de not_active Expired - Lifetime
- 2002-02-21 DK DK02723222.2T patent/DK1404312T3/da active
- 2002-02-21 PL PL02364647A patent/PL364647A1/xx unknown
- 2002-02-21 EP EP02723222A patent/EP1404312B1/en not_active Expired - Lifetime
- 2002-02-21 PT PT02723222T patent/PT1404312E/pt unknown
- 2002-02-21 AU AU2002254015A patent/AU2002254015B2/en not_active Ceased
- 2002-02-21 CA CA2439274A patent/CA2439274C/en not_active Expired - Fee Related
- 2002-02-21 ES ES02723222T patent/ES2356617T3/es not_active Expired - Lifetime
- 2002-02-21 JP JP2002567289A patent/JP4276838B2/ja not_active Expired - Fee Related
- 2002-02-21 BR BR0207673-0A patent/BR0207673A/pt not_active Application Discontinuation
- 2002-02-21 HU HU0303236A patent/HUP0303236A3/hu unknown
- 2002-02-21 AT AT02723222T patent/ATE493125T1/de active
- 2002-02-21 NZ NZ527994A patent/NZ527994A/en unknown
- 2002-02-21 KR KR1020037011260A patent/KR100906315B1/ko not_active Expired - Fee Related
- 2002-02-27 MY MYPI20020695A patent/MY129312A/en unknown
- 2002-02-27 TW TW091103502A patent/TWI304735B/zh not_active IP Right Cessation
- 2002-02-27 AR ARP020100699A patent/AR033427A1/es unknown
-
2003
- 2003-08-26 NO NO20033804A patent/NO20033804L/no not_active Application Discontinuation
- 2003-09-25 ZA ZA200307475A patent/ZA200307475B/xx unknown
-
2011
- 2011-03-22 CY CY20111100309T patent/CY1111349T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2439274A1 (en) | Carbamate compounds for use in the treatment of pain | |
| ES2738826T3 (es) | Compuestos de piridilo sustituidos con alquilamida útiles como moduladores de respuestas de IL-12, IL-23 y/o IFNalfa | |
| ES2335498T3 (es) | Nuevo proceso para la preparacion de reflumilast. | |
| HRP20230377T1 (hr) | Inhibitori mutacije kras g12c | |
| ES2228127T3 (es) | Derivados de pirazolopiridina como inhibidores selectivos de cox-2. | |
| CN1140267C (zh) | 治疗环加氧酶-2介导的疾病的每天一次的组合物 | |
| ES2216631T3 (es) | Pirazolpiridinas. | |
| JP2014139226A5 (cg-RX-API-DMAC10.html) | ||
| TW200808314A (en) | Treatment of chemokine mediated diseases | |
| ES2961499T3 (es) | Inhibidores de LSD1 y usos médicos de los mismos | |
| JP2010150273A5 (cg-RX-API-DMAC10.html) | ||
| EP1979349A2 (en) | Anti-viral compounds | |
| KR20160034316A (ko) | 글리옥사미드 치환된 피롤아미드 유도체 및 b형 간염 치료용 의약으로서의 이의 용도 | |
| CN111406063A (zh) | 作为抗癌剂的环二核苷酸 | |
| EA200400488A1 (ru) | Бензамид и гетероариламид в качестве антагонистов рецептора p2x | |
| CN1173872A (zh) | 凝血酶抑制剂 | |
| JP2011527333A5 (cg-RX-API-DMAC10.html) | ||
| JP2004517813A5 (cg-RX-API-DMAC10.html) | ||
| WO2010000031A1 (en) | Imidazopyrimidinones and uses thereof | |
| RU2007133802A (ru) | Кристаллические формы производной имидазола | |
| TW202421132A (zh) | 作為nlrp3發炎體之抑制劑之吲唑及吡唑并吡啶化合物 | |
| JP2014527057A (ja) | プロリンリッチペプチドの構造模倣物およびその使用 | |
| CN114007652A (zh) | 小分子靶向溴/乙酰蛋白及其用途 | |
| JP2017531680A (ja) | 三環式アトロプ異性体の化合物 | |
| EP4469460A1 (en) | N-oxide inhibitors of nlrp3 inflammasome |